Literature DB >> 2031839

Low-dose and heparin-free hemodialysis in children.

D F Geary1, M Gajaria, S Fryer-Keene, J Willumsen.   

Abstract

Successful heparin-free hemodialysis has been reported in adults but not in children. A preliminary study was carried out to determine whether heparin-free hemodialysis was possible in children who were considered to have a high risk of bleeding, and if so, to identify the children in whom this technique might be expected to succeed. Of 28 heparin-free procedures, 21 (75%) were successful, a major clot developed in 4, and a minor clot occurred in 3. These children were 6.76 +/- 4.57 years old and weighed 20.7 +/- 11.3 kg. An activated clotting time (ACT) of less than 170 s was recorded in five of the six patients in whom clotting was observed (normal value 146 s with a range of 110-180 s). In a second prospective study, low-dose heparin was prescribed for patients with an ACT of less than 170 s, while the remaining children again underwent heparin-free dialysis. In this study only those patients with double-lumen vascular access and a predialysis systolic blood pressure greater than 80 mmHg were included. Their mean age was 12.25 +/- 4.61 years and their weights 32.9 +/- 19.3 Kg. In 28 of 31 (90%) procedures, no clotting was observed. Minor clotting developed during the remaining 3 procedures, all in one child who weighed 8.5 kg (the only child weighing less than 10 kg). Heparin (9.6 +/- 3.2 IU/kg body weight per hour) was administered during 18 successful procedures. This study shows that heparin-free hemodialysis is possible in children, particularly, but not exclusively, those with a coagulopathy.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2031839     DOI: 10.1007/bf01095957

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  13 in total

Review 1.  Chemical and biological heterogeneity in low molecular weight heparins: implications for clinical use and standardization.

Authors:  J Fareed; J M Walenga; D Hoppensteadt; A Racanelli; E Coyne
Journal:  Semin Thromb Hemost       Date:  1989-10       Impact factor: 4.180

2.  A standard for low molecular weight heparin?

Authors:  H C Hemker
Journal:  Haemostasis       Date:  1989

3.  Severe metabolic alkalosis complicating regional citrate hemodialysis.

Authors:  S P Kelleher; G Schulman
Journal:  Am J Kidney Dis       Date:  1987-03       Impact factor: 8.860

4.  Hemodialysis without anticoagulation. One-year prospective trial in hospitalized patients at risk for bleeding.

Authors:  S J Schwab; J J Onorato; L R Sharar; P A Dennis
Journal:  Am J Med       Date:  1987-09       Impact factor: 4.965

5.  Haemodialysis without heparin is possible.

Authors:  P Glaser; R Guesde; J J Rouby; B Eurin
Journal:  Lancet       Date:  1979-09-15       Impact factor: 79.321

6.  Hemodialysis without anticoagulants: efficiency and hemostatic aspects.

Authors:  S Casati; M Moia; G Graziani; A Cantaluppi; A Citterio; P M Mannucci; C Ponticelli
Journal:  Clin Nephrol       Date:  1984-02       Impact factor: 0.975

7.  Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding.

Authors:  R V Pinnick; T B Wiegmann; D A Diederich
Journal:  N Engl J Med       Date:  1983-02-03       Impact factor: 91.245

8.  Anticoagulation rebound after hemodialysis.

Authors:  C L Hampers; M D Balufox; J P Merrill
Journal:  N Engl J Med       Date:  1966-10-06       Impact factor: 91.245

9.  Heparin free dialysis: comparative data and results in high risk patients.

Authors:  R J Caruana; R M Raja; J V Bush; M S Kramer; S J Goldstein
Journal:  Kidney Int       Date:  1987-06       Impact factor: 10.612

10.  Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent.

Authors:  R M Zusman; R H Rubin; A E Cato; D M Cocchetto; J W Crow; N Tolkoff-Rubin
Journal:  N Engl J Med       Date:  1981-04-16       Impact factor: 91.245

View more
  7 in total

1.  Anticoagulation in patients with acute kidney injury undergoing kidney replacement therapy.

Authors:  Rupesh Raina; Ronith Chakraborty; Andrew Davenport; Patrick Brophy; Sidharth Sethi; Mignon McCulloch; Timothy Bunchman; Hui Kim Yap
Journal:  Pediatr Nephrol       Date:  2021-10-19       Impact factor: 3.651

Review 2.  Critical care in uraemic children.

Authors:  J U Leititis; M Brandis
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

Review 3.  Continuous arterial-venous diahemofiltration and continuous veno-venous diahemofiltration in infants and children.

Authors:  T E Bunchman; R A Donckerwolcke
Journal:  Pediatr Nephrol       Date:  1994-02       Impact factor: 3.714

Review 4.  Hemodialysis in infants and small children.

Authors:  R A Donckerwolcke; T E Bunchman
Journal:  Pediatr Nephrol       Date:  1994-02       Impact factor: 3.714

Review 5.  Hemostatic complications in renal disorders of the young.

Authors:  M Andrew; L A Brooker
Journal:  Pediatr Nephrol       Date:  1996-02       Impact factor: 3.714

Review 6.  Chronic dialysis in the infant less than 1 year of age.

Authors:  T E Bunchman
Journal:  Pediatr Nephrol       Date:  1995       Impact factor: 3.714

Review 7.  Alternatives to standard unfractionated heparin for pediatric hemodialysis treatments.

Authors:  Andrew Davenport
Journal:  Pediatr Nephrol       Date:  2012-02-29       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.